ADCT stock

ADC Therapeutics SA (ADCT) financials · rev $40.1M

ADC Therapeutics SA (ADCT) rev $40.1M.

Cached annual income statement
LineFY2025FY2024
Revenue$81.4M$70.8M
Cost of Revenue$5.8M$5.9M
Gross Profit$75.6M$64.9M
Operating Income-$121.5M-$130.7M
Net Income-$142.6M-$157.8M
EPS (Diluted)$-1.12$-1.62
Cached annual balance sheet
LineFY2025FY2024
Total Assets$323.1M$322.0M
Current Assets$306.3M$307.4M
Cash & Equivalents$261.3M$250.9M
Inventory$4.2M$18.4M
PP&E$0$5.1M
Total Liabilities$509.0M$524.6M
Current Liabilities$70.2M$80.5M
Short-term Debt$3.0M$0
Long-term Debt$0$0
Total Debt$0$0
Shareholders' Equity-$185.8M-$202.6M
Retained Earnings-$1.64B-$1.49B
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$141.2M-$123.8M
CapEx$264.0K$867.0K
Investing Cash Flow$395.0K-$867.0K
Financing Cash Flow$150.9M$97.1M
Dividends Paid$0$0
Net Change in Cash$0$0
Free Cash Flow-$141.4M-$124.7M

FAQ

What is ADCT P/E and revenue?

ADC Therapeutics SA (ADCT) rev $40.1M.

What is ADCT revenue?

ADC Therapeutics SA last cached revenue is $81.4M (FY2025).

Is ADCT profitable?

ADC Therapeutics SA last cached net income is -$142.6M.

What are ADCT total assets?

ADC Therapeutics SA last cached total assets are $323.1M.

What is ADCT free cash flow?

ADC Therapeutics SA last cached free cash flow is -$141.4M.

Not investment advice. Cached statements, not a live tape.